Filing summary
Entity and period: The supplied filing is Dunxin Financial Holdings Limited’s annual report on Form 20-F for the fiscal year ended December 31, 2019—not a filing for Eason Technology Ltd or a 2019 fourth-quarter report. The filing says the company operates a microfinance lending business in Hubei, China, through an 80%-consolidated VIE. Financial statements are prepared under IFRS. The annual report was signed November 9, 2020.
Financial performance and position
Unless otherwise stated, amounts below are RMB millions. The company’s principal income is interest on loans.
| Metric | 2019 | 2018 | Change or context |
|---|---|---|---|
| Loan interest income | 118.4 | 141.9 | Down 16.6%; the filing attributes the decline partly to loan receivables novated to a related party. |
| Net interest income | 98.1 | 114.8 | Down 14.5%. |
| Credit impairment losses | 24.7 | 66.9 | Lower provision than 2018; all loan receivables were classified as credit-impaired at year-end 2019. |
| Net interest income after impairment | 73.4 | 47.9 | Improved as impairment charges fell. |
| Operating costs and expenses | 15.0 | 22.2 | Lower, mainly reflecting reduced headcount and expense controls. |
| Net profit | 58.6 | 8.2 | Reported profit rose sharply; 2019 income tax expense was nil, partly because accrued interest on Stage 3 loans was not taxable income. |
| Profit attributable to company shareholders | 46.9 | 6.5 | Basic and diluted EPS were RMB0.05 and RMB0.01, respectively. |
The reported 2019 profit should be viewed alongside weak cash collection: interest received was RMB3.3 million versus RMB98.2 million in 2018. The filing says 2019 interest income primarily included accrued interest on credit-impaired loans; it is therefore not equivalent to cash collected. The filing does not provide a clear comparable margin measure.
- Loans and credit quality: Gross loans and accrued interest were RMB1,039.0 million at December 31, 2019, with a RMB423.8 million impairment allowance (40.8% of outstanding loans, per the filing) and net loans of RMB615.2 million. The entire gross loan balance was classified as Stage 3. The allowance’s adequacy depends on estimated recoveries and collateral values.
- Assets and equity: Total assets were RMB663.7 million, total current assets RMB615.6 million, and shareholders’ equity RMB426.2 million. Net loans made up most current assets.
- Debt and liabilities: The balance sheet reports RMB172.9 million of loans payable, all overdue, and RMB237.6 million of total current liabilities. Contractual debt obligations of RMB172.9 million were stated to be due within one year. Separately, a summary table reports total borrowings of RMB279.0 million for 2019; this does not reconcile with the balance-sheet loans payable and should be checked against the full filing and notes.
- Liquidity: Cash, cash equivalents and restricted cash were only RMB132,000 at year-end, including RMB65,000 frozen by court order. The company reported a current-asset surplus, but these assets were overwhelmingly impaired loans rather than readily available cash.
- Cash flow: Operating cash flow was positive RMB15.1 million in 2019, but the filing attributes it in part to increased unpaid interest and loan receivables novated to a related party to offset payables. Financing cash flow was negative RMB18.5 million, and cash declined RMB3.5 million. The filing says cash decreased in each of 2017–2019.
Material changes and unusual items
- Interest income declined, while the impairment charge fell substantially from the unusually high 2018 level; lower operating expenses and no 2019 income-tax expense also contributed to higher reported net profit.
- In 2019, loan receivables were novated to Hubei New Nature, a company majority-owned by the CEO, to offset specified loan, interest and other payables. The filing identifies related-party offsets totaling RMB40.2 million in the cash-flow notes. The transaction reduced some obligations and also affected reported interest income.
- The company suspended its HiTon supply-chain finance platform in May 2019 because it lacked liquidity to fund the business.
- The filing restates 2016 and 2017 financial information to correct accounting errors, including expense accruals, reserves, EPS and cash-flow classifications. Management identified material weaknesses in internal control as of 2018; it reported none as of December 31, 2019 after remediation. The auditor did not attest to internal-control effectiveness.
Outlook, risks and contingencies
- Going concern: The independent auditor’s report states that substantial doubt exists about the company’s ability to continue as a going concern, citing recurring cash declines, litigation uncertainty and COVID-19’s adverse effects. The statements remain prepared on a going-concern basis and do not include liquidation adjustments.
- Funding plans: Management described intensified loan and interest collection, monetizing collateral, financial-support letters from CEO-affiliated entities, and plans to seek private-placement equity. The company said it believed these measures could meet anticipated needs for 12 months after issuance, but gave no assurance that additional capital would be available.
- Defaults and litigation: The company says it defaulted on loans payable beginning in 2019, could not pay some taxes, employees and service providers, and lost access to financing through securities-exchange platforms. Aggregate claims against the company were disclosed as RMB98.1 million at December 31, 2019. Court orders froze or preserved deposits and property. A court ordered repayment of a RMB10 million shareholder loan plus interest, with the CEO jointly and severally liable; a later consumer-spending restriction order against the CEO followed nonpayment.
- COVID-19 and concentration: Operations and borrowers were concentrated in Wuhan. The city lockdown beginning January 23, 2020 and related restrictions materially disrupted operations and borrowers’ ability to repay. The filing identifies further collection, liquidity and credit-loss risks.
- Structural and regulatory risks: The business is conducted through contractual VIE arrangements rather than direct ownership of the operating lender. Their enforceability is uncertain. The company also disclosed possible noncompliance with Hubei’s “small sum and decentralization” lending principle, including loans above the stated single-borrower threshold, and geographic concentration in Wuhan.
- Other outlook: No quantified earnings or revenue guidance is provided. The filing describes longer-term expansion ambitions, but notes that the new platform was suspended and that further capital is needed.
Key facts investors should verify
- Reconcile the RMB279.0 million “total borrowings” figure with RMB172.9 million of balance-sheet loans payable and the RMB172.9 million contractual debt schedule; confirm amounts overdue and any subsequent repayments or settlements.
- Assess recoverability of the RMB615.2 million net loan portfolio, including collateral valuations, borrower-level delinquency data, post-year-end collections and whether the RMB423.8 million allowance is sufficient.
- Verify the status and enforceability of the RMB98.1 million aggregate claims, frozen assets, judgments and other proceedings, including any claims or restrictions arising after the reporting date.
- Confirm whether CEO-affiliated support commitments were funded, whether private-placement financing was completed, and whether the company could meet obligations as they fell due.
- Review the related-party loan novations and offsets, their approvals and valuation, and their effect on reported income, receivables and payables.
- Reconcile the filing’s different share-count disclosures and confirm current ADS-to-share terms, ownership and dilution.